15 unchanged sentences
We have foreign exchange risk related to foreign-denominated cash, cash equivalents, and marketable securities (“foreign funds”).
−Removed: Based on the balance of foreign funds as of March 31, 2021, of $19.8 billion, an assumed 5%, 10%, and 20% adverse change to foreign exchange would result in fair value declines of $990 million, $2.0 billion, and $4.0 billion.
+Added: Based on the balance of foreign funds as of June 30, 2021, of $18.5 billion, an assumed 5%, 10%, and 20% adverse change to foreign exchange would result in fair value declines of $925 million, $1.8 billion, and $3.7 billion.
Fluctuations in fair value are recorded in “Accumulated other comprehensive income (loss),” a separate component of stockholders’ equity.
1 unchanged sentence
We have foreign exchange risk related to our intercompany balances denominated in various foreign currencies.
−Removed: Based on the intercompany balances as of March 31, 2021, an assumed 5%, 10%, and 20% adverse change to foreign exchange rates would result in losses of $230 million, $460 million, and $920 million, recorded to “Other income (expense), net.”
+Added: Based on the intercompany balances as of June 30, 2021, an assumed 5%, 10%, and 20% adverse change to foreign exchange rates would result in losses of $240 million, $480 million, and $965 million, recorded to “Other income (expense), net.”
See Item 2 of Part I, “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Results of Operations — Effect of Foreign Exchange Rates” for additional information on the effect on reported results of changes in foreign exchange rates.
Equity Investment Risk
−Removed: As of March 31, 2021, our recorded value in equity and equity warrant investments in public and private companies was $8.4 billion.
−Removed: Our equity and equity warrant investments in publicly traded companies represent $2.9 billion of our investments as of March 31, 2021, and are recorded at fair value, which is subject to market price volatility.
−Removed: We assess our equity investments in private companies for impairment.
+Added: As of June 30, 2021, our recorded value in equity and equity warrant investments in public and private companies was $9.8 billion.
+Added: Our equity and equity warrant investments in publicly traded companies represent $4.7 billion of our investments as of June 30, 2021, and are recorded at fair value, which is subject to market price volatility.
+Added: We carry our equity warrant investments in private companies at fair value and adjust our equity investments in private companies for observable price changes or impairments.
Valuations of private companies are inherently more complex due to the lack of readily available market data.
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.